PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för naproxcinod. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

24 hits

Bibliografisk träff 2012-10-11

Quality by design approach for the separation of naproxcinod and its related substances by fused core particle technology column.

Inugala UR, Pothuraju NR, Vangala RR.

J Chromatogr Sci · evaluation study; journal article · DOI 10.1093/chromsci/bms162

Bibliografisk träff 2012-07-01

Naproxcinod.

Författaruppgift saknas

Prescrire Int · journal article

Bibliografisk träff 2012-03-14

Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.

Bond M, Davis A, Lohmander S, Hawker G.

Osteoarthritis Cartilage · multicenter study; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1016/j.joca.2012.03.001

Bibliografisk träff 2011-06-01

Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration.

Björnsson MA, Simonsson US.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/j.1365-2125.2011.03924.x

Bibliografisk träff 2011-04-01

Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs.

Fiorucci S, Santucci L.

Inflamm Allergy Drug Targets · review; journal article · DOI 10.2174/187152811794776213

Bibliografisk träff 2011-04-01

Separation of the two enantiomers of naproxcinod by chiral normal-phase liquid chromatography.

Zhang K, Xue N, Yuan Z, Li L, Shi X, Cao L, Du Y.

J Chromatogr Sci · journal article · DOI 10.1093/chrsci/49.4.272

Bibliografisk träff 2011-03-02

Effects of naproxcinod on blood pressure in patients with osteoarthritis.

White WB, Schnitzer TJ, Bakris GL, Frayssinet H, Duquesroix B, Weber M.

Am J Cardiol · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.amjcard.2010.12.046

Bibliografisk träff 2011-01-25

Blood pressure effects of naproxcinod in hypertensive patients.

Townsend R, Bittar N, Rosen J, Smith W, Ramsay A, Chrysant SG, Weiss R, Pivodic A, Duquesroix B, Djian J.

J Clin Hypertens (Greenwich) · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/j.1751-7176.2010.00419.x

Bibliografisk träff 2011-01-01

[Cyclooxygenases inhibitors and other compounds with antiinflammatory potential in osteoarthrosis--part II].

Dzielska-Olczak M.

Pol Merkur Lekarski · review; journal article; english abstract

Bibliografisk träff 2011-01-01

COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.

Fiorucci S, Distrutti E.

Curr Med Chem · journal article · DOI 10.2174/092986711796642508

Bibliografisk träff 2010-12-01

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.

Baerwald C, Verdecchia P, Duquesroix B, Frayssinet H, Ferreira T.

Arthritis Rheum · multicenter study; randomized controlled trial; journal article · DOI 10.1002/art.27694

Bibliografisk träff 2010-09-09

Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study.

Schnitzer TJ, Hochberg MC, Marrero CE, Duquesroix B, Frayssinet H, Beekman M.

Semin Arthritis Rheum · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.semarthrit.2010.06.002

Bibliografisk träff 2010-08-01

Intra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donation.

Ji L, Li LP, Schnitzer T, Du H, Prasad PV.

J Magn Reson Imaging · research-article; journal article; research support, n.i.h., extramural · DOI 10.1002/jmri.22253

Bibliografisk träff 2010-08-01

Treatment strategies for osteoarthritis patients with pain and hypertension.

Verdecchia P, Angeli F, Mazzotta G, Martire P, Garofoli M, Gentile G, Reboldi G.

Ther Adv Musculoskelet Dis · review-article; journal article · DOI 10.1177/1759720x10376120

Bibliografisk träff 2010-02-16

Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.

Schnitzer TJ, Kivitz A, Frayssinet H, Duquesroix B.

Osteoarthritis Cartilage · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.joca.2009.12.013

Bibliografisk träff 2009-09-01

Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.

White WB, Schnitzer TJ, Fleming R, Duquesroix B, Beekman M.

Am J Cardiol · comparative study; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.amjcard.2009.05.014

Bibliografisk träff 2009-07-01

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol · bibliography; journal article

Bibliografisk träff 2009-06-01

Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.

Fiorucci S.

Gastroenterol Clin North Am · review; journal article · DOI 10.1016/j.gtc.2009.03.001

Bibliografisk träff 2009-05-01

Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD).

Geusens P.

Expert Opin Biol Ther · review; journal article · DOI 10.1517/14712590902926071

Bibliografisk träff 2009-05-01

Treatment of patients with hypertension and arthritis pain: new concepts.

Weber MA.

Am J Med · review; journal article · DOI 10.1016/j.amjmed.2009.03.004

Bibliografisk träff 2009-05-01

Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.

Karlsson J, Pivodic A, Aguirre D, Schnitzer TJ.

J Rheumatol · research support, non-u.s. gov't; multicenter study; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.3899/jrheum.081011

Bibliografisk träff 2009-05-01

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol · bibliography; journal article · DOI 10.1358/mf.2009.31.4.1373959

Bibliografisk träff 2007-01-01

Naproxcinod: AZD 3582, HCT 3012, naproxen nitroxybutylester, nitronaproxen, NO-naproxen.

Författaruppgift saknas

Drugs R D · review; journal article · DOI 10.2165/00126839-200708040-00006

Bibliografisk träff 2006-01-01

Nitronaproxen: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, NO-Naproxen.

Författaruppgift saknas

Drugs R D · review; journal article · DOI 10.2165/00126839-200607040-00007